
Efficacy and safety of PD-1 inhibitors in combination with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction cancer across subgroups: A comprehensive systematic review and meta-analysis
GastroenterologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Medicine
- Publicado em
- 15 ago 2025
- Citações
- 1
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and safety of PD-1 inhibitors in combination with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction cancer across subgroups: A comprehensive systematic review and meta-analysis
Muhetaibaier Hairoula, Yu Wei, Kalima Muhetaer, Xiaoli Ma, Leiyu Cao, Yan Gao, Chengcheng Qu, Wen Yi, Li Zhang
Descritores MeSH
- Immune Checkpoint Inhibitors
- Antineoplastic Combined Chemotherapy Protocols
- Esophageal Neoplasms
- Esophagogastric Junction
- Stomach Neoplasms
- Programmed Cell Death 1 Receptor
- Randomized Controlled Trials as Topic
- Clinical Trials, Phase III as Topic
- Erb-b2 Receptor Tyrosine Kinases
- Humans
Veja também
Estudos relacionados
- The efficacy and safety of PD-1/PD-L1 inhibitors in combination with chemotherapy as a first-line treatment for unresectable, locally advanced, HER2-negative gastric or gastroesophageal junction cancer: a meta-analysis of randomized controlled trials
- PD-1/PD-L1 Inhibitors in Combination With Chemo or as Monotherapy vs. Chemotherapy Alone in Advanced, Unresectable HER2-Negative Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Meta-Analysis
- Addition of immunotherapy to perioperative chemotherapy for resectable gastric and gastroesophageal junction cancer: a meta-analysis of phase 2/3 trials
- Long-term outcomes of PD-1 inhibitors plus chemotherapy as first-line treatment for advanced HER2-negative gastric cancer: an updated systematic review and meta-analysis